Role of Prucalopride, a Serotonin (5-Ht4) Receptor Agonist, for the Treatment of Chronic Constipation

Clinical and Experimental Gastroenterology - New Zealand
doi 10.2147/ceg.s8091
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prucalopride: Novel Drug for Chronic Idiopathic Constipation

International Journal of Basic & Clinical Pharmacology
2019English

Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor Agonist

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2017English

Patient Considerations in the Management of Chronic Constipation: Focus on Prucalopride

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2016English

Effect of Chronic Serotonin-2 Receptor Agonist or Antagonist Administration on Serotonin-1a Receptor Sensitivity

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
1998English

Bridgehead-Methyl Analog of SC-53116 as a 5-Ht4 Agonist

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2004English

Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2015English

Neuronal Phenotype Dependency of Agonist-Induced Internalization of the 5-Ht1a Serotonin Receptor

Journal of Neuroscience
Neuroscience
2013English

Molecular Characterization of a Purified 5-Ht4 Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Role of the Serotonin 5-Ht2a Receptor in Learning

Learning and Memory
Molecular NeurosciencePhysiological PsychologyNeuropsychologyCellularCognitive Neuroscience
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy